Identification |
Name: | 1,4,5,6,8-Pentaazaacenaphthylen-3-amine,1,5-dihydro-5-methyl-1-b-D-ribofuranosyl- |
Synonyms: | 6-Amino-4-methyl-8-(b-D-ribofuranosyl)-4H,8H-pyrrolo[4,3,2-de]pyrimido[4,5-c]pyridazine;API 2; NSC 154020; TCN; Triciribine |
CAS: | 35943-35-2 |
Molecular Formula: | C13H16 N6 O4 |
Molecular Weight: | 320.35 |
InChI: | InChI=1/C13H16N6O4/c1-18-11-7-5(10(14)17-18)2-19(12(7)16-4-15-11)13-9(22)8(21)6(3-20)23-13/h2,4,6,8-9,13,20-22H,3H2,1H3,(H2,14,17) |
Molecular Structure: |
|
Properties |
Flash Point: | 388.3°C |
Boiling Point: | 718.5°Cat760mmHg |
Density: | 2.02g/cm3 |
Refractive index: | 1.928 |
Biological Activity: | Selective inhibitor of Akt (protein kinase B) signaling; displays minimal inhibition of PKC, PKA, SGK and p38 pathways. Inhibits phosphorylation and activation of downstream targets of Akt including Bad, GSK-3 β and AFX. In vitro, induces apoptosis and growth arrest preferentially in human cancer cells with elevated levels of Akt. In mice, potently and selectively inhibits growth of Akt-overexpressing tumors. Inhibits DNA synthesis and displays antiviral activity against HIV-1 and -2. |
Flash Point: | 388.3°C |
Safety Data |
|
|